EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 39 / No 4 (Avril 2023) Med Sci (Paris), 39 4 (2023) 319-322 References
Open Access
Issue
Med Sci (Paris)
Volume 39, Number 4, Avril 2023
Page(s) 319 - 322
Section Nouvelles
DOI https://doi.org/10.1051/medsci/2023038
Published online 24 April 2023
  1. Wang B, Zhuang R, Luo X, et al. Prevalence of metabolically healthy obese and metabolically obese but normal weight in adults worldwide: A meta-analysis. Horm Metab Res 2015 ; 47 : 839–845. [CrossRef] [PubMed] [Google Scholar]
  2. Lien EC, Westermark AM, Zhang Y, et al. Low glycaemic diets alter lipid metabolism to influence tumour growth. Nature 2021; 599 : 302–7. [CrossRef] [PubMed] [Google Scholar]
  3. Bastin J, Djouadi F. Effet des régimes hypoglycémiants sur la croissance tumorale : un rôle des lipides ? Med Sci (Paris) 2022; 38 : 526–8. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  4. Rahman MS, Murphy AJ, Woollard KJ. Effects of dyslipidaemia on monocyte production and function in cardiovascular disease. Nat Rev Cardiol 2017 ; 14 : 387–400. [CrossRef] [PubMed] [Google Scholar]
  5. Deng T, Lyon CJ, Bergin S, et al. Obesity, inflammation, and cancer. Annu Rev Pathol Mech Dis 2016 ; 11 : 421–449. [CrossRef] [PubMed] [Google Scholar]
  6. Van’t Klooster CC, Ridker PM, Hjortnaes J, et al. The relation between systemic inflammation and incident cancer in patients with stable cardiovascular disease: a cohort study. Eur Heart J 2019 ; 40 : 3901–3909. [CrossRef] [PubMed] [Google Scholar]
  7. Jiang H, Gebhardt C, Umansky L, et al. Elevated chronic inflammatory factors and myeloid-derived suppressor cells indicate poor prognosis in advanced melanoma patients. Int J Cancer 2015 ; 136 : 2352–2360. [CrossRef] [PubMed] [Google Scholar]
  8. Tran T, Lavillegrand J-R, Lereverend C, et al. Mild dyslipidemia accelerates tumorigenesis through expansion of Ly6Chi monocytes and differentiation to pro-angiogenic myeloid cells. Nat Commun 2022; 13 : 5399. [CrossRef] [PubMed] [Google Scholar]
  9. Koelwyn GJ, Newman AAC, Afonso MS, et al. Myocardial infarction accelerates breast cancer via innate immune reprogramming. Nat Med 2020; 26 : 1452–8. [CrossRef] [PubMed] [Google Scholar]
  10. Potteaux S, Tedgui A. L’infarctus du myocarde accentue le phénotype immunosuppresseur et pro-tumoral des monocytes inflammatoires : un mécanisme d’aggravation du cancer par les maladies cardiovasculaires. Med Sci (Paris) 2021; 37 : 706–8. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  11. Broadfield LA, Pane AA, Talebi A, et al. Lipid metabolism in cancer: New perspectives and emerging mechanisms. Dev Cell 2021; 56 : 1363–93. [CrossRef] [PubMed] [Google Scholar]
  12. McQuade JL, Daniel CR, Hess KR, et al. Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis. Lancet Oncol 2018 ; 19 : 310–322. [CrossRef] [PubMed] [Google Scholar]
  13. Wang Z, Aguilar EG, Luna JI, et al. Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade. Nat Med 2019 ; 25 : 141–151. [CrossRef] [PubMed] [Google Scholar]
  14. Karayama M, Inui N, Inoue Y, et al. Increased serum cholesterol and long-chain fatty acid levels are associated with the efficacy of nivolumab in patients with non-small cell lung cancer. Cancer Immunol Immunother 2022; 71 : 203–17. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.